ArticleFrontiers in oncology2022

Nomograms for Predicting Disease-Free Survival in Patients With Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Receiving Neoadjuvant Therapy and Radical Surgery.

Zhenjiang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.